anti-human NAP-2 (CXCL7) polyclonal antibody Anti-Human 100 µg

In stock

Cat-Nr.
102-P191G
Size
100 µg
  €271.00

Description / anti-human NAP-2 (CXCL7) polyclonal antibody

Neutrophil Activating Peptide 2 (NAP2), Connective Tissue Activating Protein III (CTAPIII) and βthrombogulin ( βTG), are proteolytically processed carboxylterminal fragments of platelet basic protein (PBP) which is found in the alphagranules of human platelets. NAP2 is a member of the CXC chemokines. Similar to other ELR domain containing CXC chemokines such as IL8 and the GRO proteins, NAP2 has been shown to bind CXCR2 and to chemoattract and activate neutrophils. Although CTAPIII, βTG and PBP represent aminoterminal extended variants of NAP 2 and possess the same CXC chemokine domains, these proteins do not exhibit NAP2 activity. It has been shown that the additional aminoterminal residues of CTAP III masks the critical ELR receptor binding domain that is exposed on NAP2 and may account for lack of NAP2 activity.

More Information

Size 100 µg
Source Goat
Clone Nr. Goat IgG
Species Reactivity Human
Formulation lyophilized from PBS
Buffer PBS
Reconstitution Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/ml.
Stability and Storage The lyophilized antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-8°C. Frozen aliquots are stable for at least 6 months when stored at -20°C.
Preparation Produced from sera of goats pre-immunized with highly pure (>98%) recombinant hNAP-2. Anti-Human NAP-2 specific antibody was purified by affinity chromatography employing immobilized hNAP-2 matrix.
Antigen Recombinant Human NAP-2
Application ELISA, WB
Synonyms CXCL7, NAP1L4; NAP2; NAP2L; hNAP2; NAP1L4b
Uniprot ID P02775
Protein RefSeq NP_002695.1
mRNA RefSeq NM_002704.3

All prices plus VAT + possible delivery charges